BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38599731)

  • 1. Diffuse coexpression of thyroid transcription factor-1 and p40 in a non-small cell carcinoma of the lung: Second case in the female population.
    Segado Martínez M; Ruiz García G
    Rev Esp Patol; 2024; 57(2):120-122. PubMed ID: 38599731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-small cell lung carcinomas with diffuse coexpression of TTF1 and p40: clinicopathological and genomic features of 14 rare biphenotypic tumours.
    Savari O; Febres-Aldana C; Chang JC; Fanaroff RE; Ventura K; Bodd F; Paik P; Vundavalli M; Saqi A; Askin FB; Travis WD; Rekhtman N
    Histopathology; 2023 Jan; 82(2):242-253. PubMed ID: 36130728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP53, NOTCH2, and STK11 Mutations in a Rare Tumor of non-Small Cell Lung Carcinoma with Diffuse Coexpression of TTF1 and p40 in the Same Tumor Cells.
    Guo X; Dong L; Liu H; Chen X
    Int J Surg Pathol; 2023 Sep; 31(6):1041-1047. PubMed ID: 36253711
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-small cell lung carcinoma with diffuse coexpression of thyroid transcription factor-1 and ΔNp63/p40.
    Hayashi T; Takamochi K; Yanai Y; Mitani K; Tomita H; Mogushi K; Suehara Y; Takahashi F; Suzuki K; Saito T; Yao T
    Hum Pathol; 2018 Aug; 78():177-181. PubMed ID: 29410129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ΔNp63 (p40) and thyroid transcription factor-1 immunoreactivity on small biopsies or cellblocks for typing non-small cell lung cancer: a novel two-hit, sparing-material approach.
    Pelosi G; Fabbri A; Bianchi F; Maisonneuve P; Rossi G; Barbareschi M; Graziano P; Cavazza A; Rekhtman N; Pastorino U; Scanagatta P; Papotti M
    J Thorac Oncol; 2012 Feb; 7(2):281-90. PubMed ID: 22071786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ΔNp63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterization.
    Pelosi G; Rossi G; Cavazza A; Righi L; Maisonneuve P; Barbareschi M; Graziano P; Pastorino U; Garassino M; de Braud F; Papotti M
    Int J Surg Pathol; 2013 Jun; 21(3):229-39. PubMed ID: 23486764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological Characteristics and Prognosis Analysis of Lung Carcinoma With p40/TTF1 Coexpression and Lung Adenosquamous Carcinoma: Lung Carcinoma With p40/TTF1 Coexpression Is a Rare Tumor With High Metastatic Potential.
    Gao R; Zhang X; Chen X; Chen X; Jin L; Zheng H; Yu X
    Int J Surg Pathol; 2024 Feb; ():10668969241229343. PubMed ID: 38321785
    [No Abstract]   [Full Text] [Related]  

  • 8. Non-small cell lung carcinoma with focal coexpression of thyroid transcription factor-1 and Δ Np63/p40: A case report.
    Terada K; Menju T; Date H; Haga H; Yoshizawa A
    Thorac Cancer; 2024 Apr; 15(12):1029-1033. PubMed ID: 38478955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When tumor doesn't read textbook. Third case of TTF1 and p40 co-expression in the same tumour cells in a non-small cell carcinoma. A potential new entity to consider?
    Spinelli M; Khorshad J; Viola P
    Pathologica; 2019 Jun; 111(2):58-61. PubMed ID: 31388196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting Pulmonary Large-Cell Carcinoma by Targeted Next Generation Sequencing of Several Cancer Genes Pushes Genotypic-Phenotypic Correlations to Emerge.
    Pelosi G; Fabbri A; Papotti M; Rossi G; Cavazza A; Righi L; Tamborini E; Perrone F; Settanni G; Busico A; Testi MA; Maisonneuve P; De Braud F; Garassino M; Valeri B; Sonzogni A; Pastorino U
    J Thorac Oncol; 2015 Nov; 10(11):1560-9. PubMed ID: 26317919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utility of a novel triple marker (combination of TTF1, napsin A, and p40) in the subclassification of non-small cell lung cancer.
    Ao MH; Zhang H; Sakowski L; Sharma R; Illei PB; Gabrielson E; Askin F; Li QK
    Hum Pathol; 2014 May; 45(5):926-34. PubMed ID: 24746197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of dual-marker staining to differentiate between lung squamous cell carcinoma and adenocarcinoma.
    Guo R; Tian Y; Zhang N; Huang H; Huang Y; Yang J
    J Int Med Res; 2020 Apr; 48(4):300060519893867. PubMed ID: 31880186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-preserving antibody cocktails to differentiate primary squamous cell carcinoma, adenocarcinoma, and small cell carcinoma of lung.
    Brown AF; Sirohi D; Fukuoka J; Cagle PT; Policarpio-Nicolas M; Tacha D; Jagirdar J
    Arch Pathol Lab Med; 2013 Sep; 137(9):1274-81. PubMed ID: 23289761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reevaluation and reclassification of resected lung carcinomas originally diagnosed as squamous cell carcinoma using immunohistochemical analysis.
    Kadota K; Nitadori J; Rekhtman N; Jones DR; Adusumilli PS; Travis WD
    Am J Surg Pathol; 2015 Sep; 39(9):1170-80. PubMed ID: 25871623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens.
    Nishino M; Hoang MP; Della Pelle P; Morales-Oyarvide V; Huynh TG; Mark EJ; Mino-Kenudson M
    Cancer Cytopathol; 2016 Jul; 124(7):472-84. PubMed ID: 27412420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexpression of ΔNp63/p40 and TTF1 Within Most of the Same Individual Cells Identifies Life-Threatening NSCLC Featuring Squamous and Glandular Biphenotypic Differentiation: Clinicopathologic Correlations.
    Pelosi G; Bulloni M; Vescio M; Uccella S; Forest F; Leone G; Barberis M; Rahal D; Bossi P; Finzi G; Marchiori D; De Luca M; Sessa F; Harari S; Spinelli M; Viola P; Macrì P; Maria S; Rizzo A; Picone A; Pattini L
    JTO Clin Res Rep; 2021 Nov; 2(11):100222. PubMed ID: 34746884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma.
    Tran L; Mattsson JS; Nodin B; Jönsson P; Planck M; Jirström K; Botling J; Micke P; Brunnström H
    Appl Immunohistochem Mol Morphol; 2016 Oct; 24(9):648-659. PubMed ID: 26447895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expressions of Thyroid Transcription Factor-1, Napsin A, p40, p63, CK5/6 and Desmocollin-3 in Non-Small Cell Lung Cancer, as Revealed by Imprint Cytology Using a Malinol-Based Cell-Transfer Technique.
    Kawai T; Tominaga S; Hiroi S; Kameda K; Ogata S; Nakashima H; Ozeki Y; Nakanishi K
    Acta Cytol; 2015; 59(6):457-64. PubMed ID: 26696549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biphenotypic lung carcinoma with coexpression of TTF-1 and ΔNP63/P40 within most of the same individual cells: a further case confirming poor prognosis and a review of literature.
    Marando A; Zagni M; Negrelli M; Valtorta E; Lauricella C; Motta V; Veronese S; Cerea G; Giannetta LG; Ciarlo G; Signorelli D; Pizzutilo EG; Bonoldi E; Pelosi G
    Pathologica; 2024 Feb; 116(1):13-21. PubMed ID: 38482671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-small cell lung carcinoma with diffuse coexpression of thyroid transcription factor-1 and p40 in the same tumor cells: report of a case].
    Chen B; Cheng N
    Zhonghua Bing Li Xue Za Zhi; 2022 Jun; 51(6):558-560. PubMed ID: 35673733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.